In this Jan. 27, 2016, file photo, an Aedes aegypti mosquito known to carry the Zika virus, is photographed through a microscope at the Fiocruz institute in Recife, Pernambuco state, Brazil. (AP Photo/Felipe Dana, File)
Genetically modified mosquitoes are being released in the Florida Keys in an effort to combat persistent insect-borne diseases such as Dengue fever and the Zika virus.
The Florida Keys Mosquito Control District and the Oxitec biotechnology company announced Thursday that release boxes, non-release boxes and netted quality control boxes are being placed this week in six locations: two on Cudjoe Key, one on Ramrod Key and three on Vaca Key.
Starting early next month, less than 12,000 mosquitoes are expected to emerge each week for approximately 12 weeks. Untreated comparison sites will be monitored with mosquito traps on Key Colony Beach, Little Torch Key and Summerland Key.
“We really started looking at this about a decade ago, because we were in the middle of a dengue fever outbreak here in the Florida Keys,” Florida Keys Mosquito Control District executive director Andrea Leal said during a video news conference. “So we’re just very excited to move forward with this partnership, working both with Oxitec and members of the community.”
Keys officials approved the pilot project last year involving the striped-legged Aedes aegypti mosquito, which is not native to Florida. The insect transmits several diseases to humans, particularly in the Keys island chain where dozens of cases of dengue fever were reported last year.
Oxitec’s non-biting male mosquitoes are expected to mate with the local biting female mosquitoes. The female offspring of these encounters cannot survive, controlling the Aedes aegypti population. The Aedes aegypti mosquito makes up about 4% of the mosquito population in the Keys but is responsible for virtually all mosquito-borne diseases transmitted to humans. This mosquitoes transmit dengue, Zika, yellow fever and other human diseases, and can transmit heartworm and other potentially deadly diseases to pets and other animals.
An earlier version of the genetically-modified mosquitoes was used in Brazil, but this is the first time they have been used in the United States.
“We’re an organization comprised of very passionate individuals working to develop solutions that can have a public health impact,” Oxitec CEO Grey Frandsen said. “We have people living in the Keys. We have spent a huge amount of time engaging with residents, with community leaders, with small businesses, and have seen the results of that.”
Some people worry about using genetically-modified organisms, or GMOs, that they believe could alter the planet’s natural balance. Barry Wray, director of the Florida Keys Environmental Coalition, has said that officials have no idea what the insects will do.
It’s also unclear whether the genetically-modified mosquitoes will be able to accomplish their intended task, said Max Moreno, an expert in mosquito-borne diseases at Indiana University who is not involved in the company or the pilot project. Moreno has said the lab-created males might have a difficult time competing with rivals that have gone through the natural selection process, in which only the fittest survive and mate.
The genetically-modified mosquitoes have been approved by the Environmental Protection Agency and the Florida Department of Agriculture and Consumer Services, officials said. It also has support from the U.S. Centers for Disease Control and Prevention. The project is being funded by Oxitec.
After months of investigation, board members from U.S. big oil companies were slated to appear before a House oversight committee this week to discuss their respective roles in pushing for climate initiatives internally. However, all four board members from Exxon, Shell, Chevron, and BP said they couldn't attend due to scheduling conflicts. Climate experts are testifying in their place about how effective big oil's climate promises have been so far. Meanwhile, President Joe Biden's lead science adviser Eric Lander has resigned after an investigation found he violated workplace policy. What will this mean for Biden's climate agenda? Amy Harder, executive editor of Cipher, a publication by Breakthrough Energy, joins Cheddar Climate to discuss.
Although this week's weather is predicted to be less severe than the 2021 storm, Texans are preparing for the worst - stocking up on supplies and emptying shelves in grocery stores, once again. Some Texans still have not recovered from last year's tragedy, and are heading into the next few weeks with anxiety for what's to come. Leslie Beyer, CEO of the Houston-based energy workforce & technology council, joins Cheddar News to discuss if the Texas grid will fail again.
The American Red Cross has declared its first-ever "national blood crisis" in the United States. Since COVID hit the U.S. in March 2020, blood donations have declined by 10 percent. American Red Cross Medical Director, Dr. Baia Lasky joined Cheddar News to discuss the country facing the worst blood shortage in over a decade. Dr. Lasky noted that as much as 40 percent of Americans are eligible to donate blood but only about 4 percent do so. "This is going to be ongoing," she said. "This is not an acute shortage. We really do need the commitment of people to come out and donate and donate again." Appointments to donate can be made by using the Red Cross Donor App, at RedCrossBlood.org, or calling 1-800-RED CROSS (1-800-733-2767).
Eight months after the National Football League announced $1 million in research into cannabinoids, the NFL-NFLPA Joint Pain Management Committee has awarded the funding to two teams of medical researchers at the University of California San Diego and the University of Regina. The NFL says the studies will investigate the effects of cannabinoids on pain management and neuroprotection from concussion in elite football players, respectively. Cheddar correspondent Chloe Ailello spoke with Jeff Miller, the executive vice president of communications, public affairs, and policy for the NFL, about the studies, as well as the recent lawsuit filed against the NFL by former Miami Dolphins head coach Brian Flores. "Maybe we can learn things from other alternative pain approaches that are going to benefit our player population and then sports medicine as a whole," Miller said.
On this episode of Cheddar Innovates: CEO of HereAfter AI discusses how artificial intelligence can be used to preserve family history and stories, and allow you to 'talk' to loved ones that have passed; Creator of the board game 'Travel Explore Discover' explains how she came up with the idea for this informative and educational board game, and how she's using the proceeds to give back to her community; Cheddar gets a look at Curiosity Stream's 'The Humboldt Current.'
Immunologist Dr. Purvi Parikh of the Allergy & Asthma Network joined Cheddar News to break down long Covid, in which Covid symptoms remain up to two years after infection; a phenomenon that has so far mystified health experts.
Solid-state battery maker Factorial Energy recently raised $200 million in a Series D round led by Mercedes-Benz and Stellantis. Factorial says the funding will be used to accelerate commercial production and deployment of its solid-state battery technology, which the company says is safer, and offers up to 50% more driving range than current lithium-ion technology. Factorial also has joint development agreements (announced in late 2021) with Mercedes-Benz, Stellantis, and Hyundai, three of the top 10 global automotive manufacturers, to commercialize its batteries. Factorial CEO Siyu Huang joined Cheddar News' Closing Bell to discuss.
David Malott, founder and chief architect at AI PlanetWorks joins Cheddar News to discuss the release of its augmented reality NFTs for the metaverse called 'TERA.'
A 2021 report from UK Research and Innovation found that the shipping industry makes up at least 2.5 percent of the world's total CO2 emissions. It's a problem that energy solutions company, Leclanché, is trying to solve. Founded in 1909, the company has been developing and producing batteries for more than 100 years. Today, Leclanché's lithium-ion battery is used to electrify not just ships, but also railroad locomotives, trucks, and specialty vehicles. Cheddar News spoke with Pierre Blanc, chief technology and industrial officer of Leclanché, to discuss.
